Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
University of Toronto and Insilico Medicine Announce Breakthrough in Quantum AI for Drug Discovery
A recent study led by researchers from the University of Toronto and Insilico Medicine has demonstrated the potential of quantum computing and artificial intelligence (AI) in transforming the drug discovery process. ...
UCLA Health Advances Breakthrough Targeted Therapies for Breast Cancer
Targeted therapies are transforming the treatment of breast cancer, leading to significant improvements in both survival rates and patients' quality of life. ...
Bluejay Therapeutics Receives FDA Breakthrough Designation for Chronic Hepatitis Delta
Bluejay Therapeutics, a clinical-stage biopharmaceutical company focused on developing potential treatments for serious viral and liver diseases, has announced that its lead product candidate, brelovitug (also known as BJT-778)...
Vanda Pharmaceuticals Introduces Novel Orphan Drug VGT-1849A for the Treatment of Polycythemia Vera
Vanda Pharmaceuticals has announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for VGT-1849A, a selective antisense oligonucleotide (ASO)-based JAK2 inhibitor. This investigational therapy is being developed...
Eli Lilly Announces Zepbound® as the First Prescription Medicine for Obesity-Related Sleep Apnea
Eli Lilly and Company has announced that the U.S. Food and Drug Administration has approved Zepbound® (tirzepatide) as the first prescription treatment for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity....
Firefly Neuroscience Introduces Innovative Brain Age Biomarker for Early Alzheimer’s Detection with FDA-Cleared BNA™ Platform
Firefly Neuroscience has announced significant progress in its research on brain age assessment. The development leverages the company’s FDA-cleared BNA™ technology platform....
FDA Approves First Mesenchymal Stromal Cell (MSC) Therapy, a Major Milestone in Regenerative Medicine
The Food and Drug Administration (FDA) has approved RYONCIL®, the first mesenchymal stromal cell (MSC) therapy, for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD) in children aged two months and older....
Innovent Announces Breakthrough Therapy Designation for IBI343 in Advanced Pancreatic Cancer
Innovent Biologics has announced that the Centre for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted a Breakthrough Therapy Designation (BTD) for IBI343. This is a potentially best-in-class TOPO1i anti-CLDN18.2...
Gilead's Trodelvy® Receives Breakthrough Therapy Designation for Extensive-Stage Small Cell Lung Cancer
Gilead Sciences has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Trodelvy® (sacituzumab govitecan-hziy) in the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) whose disease has progressed after platinum-based chemotherapy....
Tolebrutinib Receives Breakthrough Therapy Designation for Non-Relapsing Secondary Progressive Multiple Sclerosis
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to tolebrutinib for the treatment of adults with non-relapsing secondary progressive multiple sclerosis (nrSPMS). ...
